Victory Capital Management
CATX icon

Victory Capital Management’s Perspective Therapeutics CATX Stock Holding History

Victory Capital Management’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.6K Sell
10,428
-139
-1% -$525 ﹤0.01% 2413
2026
Q1 		$44.1K Buy
+10,567
New +$44.6K ﹤0.01% 2320
2025
Q1 		– Sell
-49,420
Closed -$158K – 2481
2024
Q4 		$158K Sell
49,420
-1,040
-2% -$8.49K ﹤0.01% 2274
2024
Q3 		$674K Buy
50,460
+38,690
+329% +$515K ﹤0.01% 1928
2024
Q2 		$117K Buy
+11,770
New +$170K ﹤0.01% 2274
2023
Q1 		– Sell
-1,596
Closed -$3.94K – 2604
2022
Q4 		$3.94K Sell
1,596
-1
-0.1% -$3 ﹤0.01% 2574
2022
Q3 		$4K Sell
1,597
-398
-20% -$1.36K ﹤0.01% 2683
2022
Q2 		$6K Sell
1,995
-14
-0.7% -$43 ﹤0.01% 2673
2022
Q1 		$6K Sell
2,009
-55
-3% -$201 ﹤0.01% 2698
2021
Q4 		$8K Sell
2,064
-58
-3% -$309 ﹤0.01% 2736
2021
Q3 		$13K Sell
2,122
-107
-5% -$729 ﹤0.01% 2749
2021
Q2 		$18K Sell
2,229
-65
-3% -$569 ﹤0.01% 2711
2021
Q1 		$25K Buy
2,294
+833
+57% +$12.6K ﹤0.01% 2709
2020
Q4 		$7K Buy
1,461
+386
+36% +$1.71K ﹤0.01% 2523
2020
Q3 		$6K Sell
1,075
-62
-5% -$404 ﹤0.01% 2470
2020
Q2 		$6K Sell
1,137
-35
-3% -$225 ﹤0.01% 2484
2020
Q1 		$6K Buy
+1,172
New +$8.85K ﹤0.01% 3228
2019
Q4 		– Sell
-1,204
Closed -$4K – 2734
2019
Q3 		$4K Buy
+1,204
New +$4.36K ﹤0.01% 3495

Other funds holding CATX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Victory Capital Management's CATX Position: Q2 2026 in Review

Victory Capital Management reduced its Perspective Therapeutics (CATX) stake by 1.3% in Q2 2026, selling an estimated $525 and leaving 10,428 shares worth $35.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2413.

Victory Capital Management first reported a position in CATX in Q3 2019 and has held it in 18 quarters since. The position peaked at $674K in Q3 2024. 131 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

  • Victory Capital Management held 10,428 shares of Perspective Therapeutics worth $35.6K as of Q2 2026.
  • Victory Capital Management sold 139 Perspective Therapeutics shares in Q2 2026, an estimated $525.
  • Perspective Therapeutics made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #2413 holding.
  • Victory Capital Management first reported a position in Perspective Therapeutics in Q3 2019 and has held it in 18 quarters since.
  • Victory Capital Management's Perspective Therapeutics position peaked at $674K in Q3 2024.
  • 131 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.